\-\ Texto\\:\\ \ \(0\)\
\-\ well\\-appearing\\ woman\\ in\\ no\\ acute\\ distress\\.\\ \\ neurologically\\,\\ she\\ was\\ alert\\ and\\ oriented\\.\\ \\ pupils\\ were\\ equal\\ and\\ reactive\\.\\ \\ \\ extraocular\\ movements\\ were\\ intact\\.\\ \\ no\\ visual\\ field\\ deficits\\ were\\ revealed\\.\\ \\ she\\ moved\\ all\\ extremities\\ symmetrically\\.\ \(0\)\
\-\ vancomycin\\ 1g\\ iv\\ q12\\,\\ ceftazidime\\ 2g\\ iv\\ q8\\,\\ and\ \(0\)\
\-\ metronidazole\\ 500\\ mg\\ iv\\ q6\ \(0\)\
\-\ axial\\ t2\\ fast\\ spin\\ echo\\ image\\ demonstrates\\ a\\ high\\ right\\ parietal\\ lobe\\ lesion\\ with\\ surrounding\\ vasogenic\\ edema\\.\\ \\ axial\\ diffusion\\-weighted\\ image\\ reveals\\ restricted\\ diffusion\\ in\\ the\\ lesion\\.\\ \\ sagittal\\ post\\-contrast\\ t1\\-weighted\\ mr\\ image\\ demonstrates\\ a\\ rim\\-enhancing\\ mass\\ with\\ surrounding\\ edema\\.\ \(0\)\
\-\ brain\\ abscess\ \(13\)\
\-\ \\"magic\\ dr\\"\ \(0\)\
\-\ 1\\.\\ metastatic\\ lesion\\:\\ carcinoma\\ and\\ sarcomas\\.\\ \\ must\\ also\\ consider\\ primary\\ tumors\\:\\ high\\ grade\\ glioma\\,\\ meningioma\\,\\ lymphoma\\,\\ leukemia\\,\\ pituitary\\ macrodenoma\\,\\ acoustic\\ \ \(0\)\
\-\ neuroma\\,\\ craniopharyngioma\\.\ \(1\)\
\-\ 2\\.\\ abscess\\:\\ bacterial\\,\\ fungal\\,\\ parasitic\\ and\\ empyema\\ \\(\\ epidural\\,\\ \\ subdural\\ \\)\ \(0\)\
\-\ 3\\.\\ glioma\ \(0\)\
\-\ 4\\.\\ infarct\\ \\(resolving\\ infarction\\,\\ \\ aging\\ hematoma\\,\\ \\ operative\\ bed\\ following\\ resection\\,\\ \\ thrombosed\\ aneurysm\\)\ \(0\)\
\-\ 5\\.\\ contusion\ \(0\)\
\-\ 6\\.\\ de\\-\\ myelinating\\ disease\\:\\ radiation\\ necrosis\\ and\\ necrotizing\\ leukoencephalopathy\\ with\\ methotrexate\ \(0\)\
\-\ 7\\.\\ resolving\\ hematoma\ \(0\)\
\-\ 75\\-year\\-old\\ woman\\ who\\ initially\\ presented\\ with\\ left\\-sided\\ weakness\\ and\\ headache\ \(1\)\
\-\ it\\ is\\ difficult\\ to\\ differentiate\\ various\\ types\\ of\\ abscesses\\ and\\ cystic\\ brain\\ tumors\\ such\\ as\\ high\\-grade\\ gliomas\\ and\\ metastases\\ with\\ conventional\\ imaging\\.\\ \\ \\ abscesses\\ typically\\ occur\\ more\\ frequently\\ in\\ the\\ first\\ 4\\ decades\\ of\\ life\\ with\\ a\\ triad\\ of\\ fever\\,\\ headache\\ \\(often\\ severe\\ and\\ on\\ the\\ side\\ of\\ the\\ abscess\\)\\,\\ and\\ focal\\ neurologic\\ deficit\\ in\\ about\\ \\ half\\ of\\ patients\\.\\ brain\\ abscesses\\ are\\ rare\\ in\\ immunocompetent\\ individuals\\ and\\ more\\ typically\\ seen\\ in\\ immunosuppressed\\ individuals\\,\\ such\\ as\\ patients\\ with\\ aids\\,\\ bone\\ marrow\\ and\\ solid\\ organ\\ transplants\\,\\ and\\ neutropenia\\.\\ \\ in\\ adults\\,\\ common\\ primary\\ sources\\ of\\ infection\\ include\\ ear\\ and\\ sinus\\ infections\\,\\ otitis\\ and\\ dental\\ abscesses\\.\\ \\ among\\ the\\ common\\ distant\\ foci\\ of\\ infection\\ are\\ hematogenous\\ spread\\ of\\ infection\\ from\\ a\\ distant\\ site\\ such\\ as\\ \\ pyogenic\\ lung\\ processes\\ and\\ endocarditis\\ \\.\\ \\ in\\ young\\ children\\ however\\,\\ bacterial\\ meningitis\\,\\ has\\ decreased\\ significantly\\ due\\ to\\ the\\ haemophilus\\ influenzae\\ vaccine\\.\\ \ \(0\)\
\-\ the\\ development\\ of\\ abscess\\ is\\ characterized\\ by\\ four\\ stage\\:\\ early\\ cerebritis\\,\\ late\\ cerebritis\\,\\ early\\ capsule\\ formation\\,\\ and\\ late\\ capsule\\ formation\\.\ \(0\)\
\-\ many\\ authorities\\ consider\\ mri\\ \\ imaging\\ has\\ the\\ advantage\\ over\\ ct\\ for\\ evaluating\\ the\\ early\\ cerebritis\\ stage\\ of\\ brain\\ abscesses\\.\\ \\ t1\\-weighted\\ images\\ enhance\\ the\\ abscess\\ capsule\\,\\ the\\ abscess\\ center\\ is\\ hypointense\\ and\\ after\\ gadolinium\\ there\\ is\\ enhancement\\ of\\ the\\ abscess\\ rim\\.\\ \\ on\\ t2\\-weighted\\ images\\ the\\ abscess\\ can\\ demonstrate\\ the\\ edema\\ zone\\ around\\ the\\ abscess\\.\\ \\ diffusion\\-weighted\\ \\ imaging\\ \\(dwi\\)\\ may\\ also\\ be\\ useful\\ in\\ distinguishing\\ abscesses\\ from\\ cystic\\ brain\\ tumors\\.\\ cerebral\\ abscess\\ will\\ usually\\ have\\ restricted\\ diffusion\\ and\\ is\\ hyperintense\\ on\\ diffusion\\-weighted\\ images\\,\\ \\ while\\ cystic\\ or\\ necrotic\\ tumor\\ typically\\ has\\ free\\ diffusion\\ and\\ is\\ hypointense\\ on\\ such\\ images\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ abscess\\:\\ 0\\.29301974012668774\ \(0\)\
\-\ abscesses\\:\\ 0\\.27792090857489815\ \(0\)\
\-\ diffusion\\:\\ 0\\.23062971493464424\ \(0\)\
\-\ and\\:\\ 0\\.19801767774304455\ \(0\)\
\-\ cerebritis\\:\\ 0\\.16249915216792277\ \(0\)\
\-\ brain\\:\\ 0\\.14223613792433676\ \(0\)\
\-\ the\\:\\ 0\\.13658028695743882\ \(0\)\
\-\ capsule\\:\\ 0\\.13395059504894616\ \(0\)\
\-\ such\\:\\ 0\\.11741279555356075\ \(0\)\
\-\ in\\:\\ 0\\.10216713628691639\ \(0\)\
\-\ tumors\\:\\ 0\\.1006812323748546\ \(0\)\
\-\ resolving\\:\\ 0\\.10062375309916048\ \(0\)\
\-\ early\\:\\ 0\\.09868017613027635\ \(0\)\
\-\ of\\:\\ 0\\.09823102534274973\ \(0\)\
\-\ iv\\:\\ 0\\.09781596984075595\ \(0\)\
\-\ typically\\:\\ 0\\.09610370349767298\ \(0\)\
\-\ individuals\\:\\ 0\\.0954434248806914\ \(0\)\
\-\ distant\\:\\ 0\\.0954434248806914\ \(0\)\
\-\ consider\\:\\ 0\\.08977099478775907\ \(0\)\
\-\ image\\:\\ 0\\.08755112908006922\ \(0\)\
\-\ late\\:\\ 0\\.08615319299588749\ \(0\)\
\-\ bacterial\\:\\ 0\\.08540891082168826\ \(0\)\
\-\ images\\:\\ 0\\.08443241849871923\ \(0\)\
\-\ infection\\:\\ 0\\.08269414974667533\ \(0\)\
\-\ cystic\\:\\ 0\\.08244884499824937\ \(0\)\
\-\ edema\\:\\ 0\\.08164881183989295\ \(0\)\
\-\ hypointense\\:\\ 0\\.08031391177355855\ \(0\)\
\-\ restricted\\:\\ 0\\.07844417798309947\ \(0\)\
\-\ high\\:\\ 0\\.07780369951296366\ \(0\)\
\-\ glioma\\:\\ 0\\.07752969014499421\ \(0\)\
\-\ is\\:\\ 0\\.07498074637465384\ \(0\)\
\-\ q8\\:\\ 0\\.07297642382998526\ \(0\)\
\-\ magic\\:\\ 0\\.07297642382998526\ \(0\)\
\-\ macrodenoma\\:\\ 0\\.07297642382998526\ \(0\)\
\-\ myelinating\\:\\ 0\\.07297642382998526\ \(0\)\
\-\ stage\\:\\ 0\\.07267895815475227\ \(0\)\
\-\ rim\\:\\ 0\\.07267895815475227\ \(0\)\
\-\ formation\\:\\ 0\\.07235409051574662\ \(0\)\
\-\ imaging\\:\\ 0\\.07194438955547472\ \(0\)\
\-\ were\\:\\ 0\\.07056682364920051\ \(0\)\
\-\ 1g\\:\\ 0\\.06973286889877932\ \(0\)\
\-\ 2g\\:\\ 0\\.06973286889877932\ \(0\)\
\-\ q6\\:\\ 0\\.06743153005097001\ \(0\)\
\-\ authorities\\:\\ 0\\.06743153005097001\ \(0\)\
\-\ ceftazidime\\:\\ 0\\.06564647296033885\ \(0\)\
\-\ immunosuppressed\\:\\ 0\\.06564647296033885\ \(0\)\
\-\ influenzae\\:\\ 0\\.06564647296033885\ \(0\)\
\-\ lesion\\:\\ 0\\.06563181668815737\ \(0\)\
\-\ grade\\:\\ 0\\.06562758693740191\ \(0\)\
\-\ q12\\:\\ 0\\.06418797511976407\ \(0\)\
\-\ immunocompetent\\:\\ 0\\.06418797511976407\ \(0\)\
\-\ haemophilus\\:\\ 0\\.06418797511976407\ \(0\)\
\-\ hematoma\\:\\ 0\\.06387866696900452\ \(0\)\
\-\ headache\\:\\ 0\\.0629142924163569\ \(0\)\
\-\ with\\:\\ 0\\.06254800259080855\ \(0\)\
\-\ has\\:\\ 0\\.06253089376953352\ \(0\)\
\-\ neutropenia\\:\\ 0\\.06188663627195476\ \(0\)\
\-\ transplants\\:\\ 0\\.06094442018855812\ \(0\)\
\-\ surrounding\\:\\ 0\\.06086728056265706\ \(0\)\
\-\ vaccine\\:\\ 0\\.06010157918132359\ \(0\)\
\-\ aging\\:\\ 0\\.0593391367478899\ \(0\)\
\-\ neurologically\\:\\ 0\\.05864308134074881\ \(0\)\
\-\ metronidazole\\:\\ 0\\.058002772436259016\ \(0\)\
\-\ sarcomas\\:\\ 0\\.057409938987180206\ \(0\)\
\-\ advantage\\:\\ 0\\.057409938987180206\ \(0\)\
\-\ moved\\:\\ 0\\.05685802425011764\ \(0\)\
\-\ primary\\:\\ 0\\.05611822324106436\ \(0\)\
\-\ symmetrically\\:\\ 0\\.0558567703285955\ \(0\)\
\-\ neuroma\\:\\ 0\\.05539952640954286\ \(0\)\
\-\ distinguishing\\:\\ 0\\.05539952640954286\ \(0\)\
\-\ on\\:\\ 0\\.0551272853174925\ \(0\)\
\-\ as\\:\\ 0\\.05499667631589438\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.05496701076599944\ \(0\)\
\-\ vancomycin\\:\\ 0\\.05455668540230833\ \(0\)\
\-\ sources\\:\\ 0\\.05455668540230833\ \(0\)\
\-\ she\\:\\ 0\\.05432797104051631\ \(0\)\
\-\ thrombosed\\:\\ 0\\.05416638405597426\ \(0\)\
\-\ endocarditis\\:\\ 0\\.05416638405597426\ \(0\)\
\-\ triad\\:\\ 0\\.053794242968874646\ \(0\)\
\-\ dr\\:\\ 0\\.053098187561733554\ \(0\)\
\-\ gliomas\\:\\ 0\\.052771628311677164\ \(0\)\
\-\ axial\\:\\ 0\\.05271803421101833\ \(0\)\
\-\ t2\\:\\ 0\\.0525073616226042\ \(0\)\
\-\ otitis\\:\\ 0\\.05215597147833692\ \(0\)\
\-\ 500\\:\\ 0\\.05186504520816495\ \(0\)\
\-\ hematogenous\\:\\ 0\\.05186504520816495\ \(0\)\
\-\ pyogenic\\:\\ 0\\.05186504520816495\ \(0\)\
\-\ common\\:\\ 0\\.05175779517927002\ \(0\)\
\-\ decades\\:\\ 0\\.05158432901054331\ \(0\)\
\-\ patients\\:\\ 0\\.051341639686324575\ \(0\)\
\-\ spin\\:\\ 0\\.051313130471102385\ \(0\)\
\-\ methotrexate\\:\\ 0\\.051313130471102385\ \(0\)\
\-\ dental\\:\\ 0\\.0505506880376687\ \(0\)\
\-\ fast\\:\\ 0\\.05031187654958024\ \(0\)\
\-\ more\\:\\ 0\\.05011433031988135\ \(0\)\
\-\ extraocular\\:\\ 0\\.04963545204985448\ \(0\)\
\-\ parasitic\\:\\ 0\\.04963545204985448\ \(0\)\
\-\ aids\\:\\ 0\\.04963545204985448\ \(0\)\
\-\ empyema\\:\\ 0\\.04921432372603781\ \(0\)\
\-\ among\\:\\ 0\\.04824934918985939\ \(0\)\
\-\ differentiate\\:\\ 0\\.048069575539896436\ \(0\)\
\-\ necrotizing\\:\\ 0\\.0477217124403457\ \(0\)\
\-\ woman\\:\\ 0\\.04753118993300686\ \(0\)\
\-\ bed\\:\\ 0\\.04738834792339039\ \(0\)\
\-\ organ\\:\\ 0\\.0469129848782285\ \(0\)\
\-\ conventional\\:\\ 0\\.046611077699321664\ \(0\)\
\-\ evaluating\\:\\ 0\\.04590268676042672\ \(0\)\
\-\ demonstrates\\:\\ 0\\.045850620294844116\ \(0\)\
\-\ acoustic\\:\\ 0\\.045768236692087134\ \(0\)\
\-\ various\\:\\ 0\\.04563600904097458\ \(0\)\
\-\ pupils\\:\\ 0\\.04525195493490899\ \(0\)\
\-\ movements\\:\\ 0\\.04500579425865344\ \(0\)\
\-\ vasogenic\\:\\ 0\\.044885497393879537\ \(0\)\
\-\ contusion\\:\\ 0\\.044885497393879537\ \(0\)\
\-\ processes\\:\\ 0\\.044885497393879537\ \(0\)\
\-\ subdural\\:\\ 0\\.044766982770564984\ \(0\)\
\-\ necrotic\\:\\ 0\\.044421623063542026\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.04409055827083922\ \(0\)\
\-\ zone\\:\\ 0\\.04409055827083922\ \(0\)\
\-\ equal\\:\\ 0\\.04366942994702257\ \(0\)\
\-\ useful\\:\\ 0\\.043567522954157174\ \(0\)\
\-\ dwi\\:\\ 0\\.04336752276811572\ \(0\)\
\-\ deficit\\:\\ 0\\.04317240112514801\ \(0\)\
\-\ half\\:\\ 0\\.04298192567993382\ \(0\)\
\-\ meningitis\\:\\ 0\\.04298192567993382\ \(0\)\
\-\ also\\:\\ 0\\.04292851223738824\ \(0\)\
\-\ field\\:\\ 0\\.04288836214834787\ \(0\)\
\-\ significantly\\:\\ 0\\.04288836214834787\ \(0\)\
\-\ adults\\:\\ 0\\.04261406359307383\ \(0\)\
\-\ types\\:\\ 0\\.04243628759345395\ \(0\)\
\-\ echo\\:\\ 0\\.04226237659729481\ \(0\)\
\-\ pituitary\\:\\ 0\\.042092166117337765\ \(0\)\
\-\ alert\\:\\ 0\\.04200840000370305\ \(0\)\
\-\ characterized\\:\\ 0\\.04192550194831423\ \(0\)\
\-\ leukemia\\:\\ 0\\.04168184075364666\ \(0\)\
\-\ ear\\:\\ 0\\.04152342783935904\ \(0\)\
\-\ epidural\\:\\ 0\\.04144538243244007\ \(0\)\
\-\ center\\:\\ 0\\.041291539407312575\ \(0\)\
\-\ oriented\\:\\ 0\\.041140599254668085\ \(0\)\
\-\ spread\\:\\ 0\\.04099245445131638\ \(0\)\
\-\ fungal\\:\\ 0\\.04084700333963327\ \(0\)\
\-\ enhance\\:\\ 0\\.04084700333963327\ \(0\)\
\-\ infections\\:\\ 0\\.04029028548579043\ \(0\)\
\-\ mg\\:\\ 0\\.0398330415667378\ \(0\)\
\-\ deficits\\:\\ 0\\.03922208899154973\ \(0\)\
\-\ reactive\\:\\ 0\\.039163483668942005\ \(0\)\
\-\ must\\:\\ 0\\.03910530457063346\ \(0\)\
\-\ visual\\:\\ 0\\.038933263730124505\ \(0\)\
\-\ operative\\:\\ 0\\.038279872908153094\ \(0\)\
\-\ gadolinium\\:\\ 0\\.038022629175141924\ \(0\)\
\-\ infarct\\:\\ 0\\.0379721584035776\ \(0\)\
\-\ marrow\\:\\ 0\\.03792200406526257\ \(0\)\
\-\ difficult\\:\\ 0\\.037872162217064846\ \(0\)\
\-\ development\\:\\ 0\\.03772447326981249\ \(0\)\
\-\ young\\:\\ 0\\.03762750734613275\ \(0\)\
\-\ frequently\\:\\ 0\\.03757946161157292\ \(0\)\
\-\ life\\:\\ 0\\.037437031900918565\ \(0\)\
\-\ children\\:\\ 0\\.037390113345557044\ \(0\)\
\-\ foci\\:\\ 0\\.03729709380028644\ \(0\)\
\-\ four\\:\\ 0\\.03697978798186593\ \(0\)\
\-\ metastases\\:\\ 0\\.03689139381443869\ \(0\)\
\-\ parietal\\:\\ 0\\.03684756033075338\ \(0\)\
\-\ site\\:\\ 0\\.03680396572282415\ \(0\)\
\-\ distress\\:\\ 0\\.036760607401192795\ \(0\)\
\-\ neurologic\\:\\ 0\\.03646350622468779\ \(0\)\
\-\ around\\:\\ 0\\.03642194981561214\ \(0\)\
\-\ hyperintense\\:\\ 0\\.03629856036535988\ \(0\)\
\-\ from\\:\\ 0\\.036246649414617325\ \(0\)\
\-\ many\\:\\ 0\\.035978534060343785\ \(0\)\
\-\ infarction\\:\\ 0\\.035823197320197994\ \(0\)\
\-\ initially\\:\\ 0\\.035784829904888814\ \(0\)\
\-\ free\\:\\ 0\\.035521290141291156\ \(0\)\
\-\ sagittal\\:\\ 0\\.035088774497747735\ \(0\)\
\-\ solid\\:\\ 0\\.03498420319486363\ \(0\)\
\-\ necrosis\\:\\ 0\\.03488098123680136\ \(0\)\
\-\ aneurysm\\:\\ 0\\.034745391706775174\ \(0\)\
\-\ reveals\\:\\ 0\\.03471185039659996\ \(0\)\
\-\ extremities\\:\\ 0\\.03467844913405663\ \(0\)\
\-\ are\\:\\ 0\\.034630974737812445\ \(0\)\
\-\ rare\\:\\ 0\\.03444846559325794\ \(0\)\
\-\ meningioma\\:\\ 0\\.034193476969712616\ \(0\)\
\-\ about\\:\\ 0\\.03416216737687849\ \(0\)\
\-\ occur\\:\\ 0\\.0335604107916182\ \(0\)\
\-\ weakness\\:\\ 0\\.033303717407116566\ \(0\)\
\-\ intact\\:\\ 0\\.03302784211176504\ \(0\)\
\-\ sinus\\:\\ 0\\.032973790617226294\ \(0\)\
\-\ cerebral\\:\\ 0\\.031614667852813624\ \(0\)\
\-\ side\\:\\ 0\\.03152427603504332\ \(0\)\
\-\ fever\\:\\ 0\\.030939471885802743\ \(0\)\
\-\ first\\:\\ 0\\.030794585298360884\ \(0\)\
\-\ radiation\\:\\ 0\\.030239936125873564\ \(0\)\
\-\ revealed\\:\\ 0\\.02992103565166043\ \(0\)\
\-\ often\\:\\ 0\\.029775253197942022\ \(0\)\
\-\ no\\:\\ 0\\.029678389179028753\ \(0\)\
\-\ mr\\:\\ 0\\.029526356964173495\ \(0\)\
\-\ while\\:\\ 0\\.029491424197931895\ \(0\)\
\-\ will\\:\\ 0\\.029370346999473784\ \(0\)\
\-\ resection\\:\\ 0\\.029251075066252494\ \(0\)\
\-\ severe\\:\\ 0\\.02888739467878582\ \(0\)\
\-\ usually\\:\\ 0\\.02872739753026048\ \(0\)\
\-\ decreased\\:\\ 0\\.02826575460600641\ \(0\)\
\-\ lung\\:\\ 0\\.02775882362810131\ \(0\)\
\-\ following\\:\\ 0\\.027375208108113155\ \(0\)\
\-\ carcinoma\\:\\ 0\\.027295344641891844\ \(0\)\
\-\ focal\\:\\ 0\\.027295344641891844\ \(0\)\
\-\ lymphoma\\:\\ 0\\.027177024790883096\ \(0\)\
\-\ all\\:\\ 0\\.027163985520258154\ \(0\)\
\-\ include\\:\\ 0\\.027150967468960122\ \(0\)\
\-\ however\\:\\ 0\\.027009149897709375\ \(0\)\
\-\ presented\\:\\ 0\\.026610333818525383\ \(0\)\
\-\ lobe\\:\\ 0\\.02637080721929738\ \(0\)\
\-\ enhancement\\:\\ 0\\.026265316581727757\ \(0\)\
\-\ due\\:\\ 0\\.02623045992197178\ \(0\)\
\-\ who\\:\\ 0\\.02581260225918043\ \(0\)\
\-\ over\\:\\ 0\\.025373718666657285\ \(0\)\
\-\ metastatic\\:\\ 0\\.025027185396842334\ \(0\)\
\-\ bone\\:\\ 0\\.024898555934268686\ \(0\)\
\-\ acute\\:\\ 0\\.024685479176852407\ \(0\)\
\-\ can\\:\\ 0\\.02394653041891664\ \(0\)\
\-\ tumor\\:\\ 0\\.023868485011997672\ \(0\)\
\-\ demonstrate\\:\\ 0\\.023723111644365698\ \(0\)\
\-\ mri\\:\\ 0\\.023423715716698202\ \(0\)\
\-\ it\\:\\ 0\\.02335867803522743\ \(0\)\
\-\ may\\:\\ 0\\.022963751311049982\ \(0\)\
\-\ to\\:\\ 0\\.022816108904533526\ \(0\)\
\-\ have\\:\\ 0\\.02279597490710662\ \(0\)\
\-\ after\\:\\ 0\\.022137110840323243\ \(0\)\
\-\ seen\\:\\ 0\\.021483447469179472\ \(0\)\
\-\ by\\:\\ 0\\.019378238490273984\ \(0\)\
\-\ disease\\:\\ 0\\.019154934443401442\ \(0\)\
\-\ be\\:\\ 0\\.018511311935512975\ \(0\)\
\-\ there\\:\\ 0\\.018157060511686522\ \(0\)\
\-\ mass\\:\\ 0\\.017430425995015732\ \(0\)\
\-\ ct\\:\\ 0\\.017372750253055142\ \(0\)\
\-\ was\\:\\ 0\\.01590340464287064\ \(0\)\
\-\ or\\:\\ 0\\.01587476076233023\ \(0\)\
\-\ right\\:\\ 0\\.015129087147206425\ \(0\)\
\-\ for\\:\\ 0\\.01383088367731923\ \(0\)\
